PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 31 filers reported holding PDS BIOTECHNOLOGY CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,000 | -20.0% | 6,850 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $25,000 | -40.5% | 6,850 | 0.0% | 0.01% | -30.0% |
| Q1 2022 | $42,000 | -16.0% | 6,850 | +9.6% | 0.01% | -9.1% |
| Q4 2021 | $50,000 | -46.2% | 6,250 | 0.0% | 0.01% | -52.2% |
| Q3 2021 | $93,000 | +19.2% | 6,250 | 0.0% | 0.02% | +15.0% |
| Q2 2021 | $78,000 | +122.9% | 6,250 | -19.4% | 0.02% | +100.0% |
| Q1 2021 | $35,000 | -7.9% | 7,750 | -56.6% | 0.01% | -16.7% |
| Q4 2020 | $38,000 | +660.0% | 17,850 | +693.3% | 0.01% | +500.0% |
| Q3 2020 | $5,000 | +66.7% | 2,250 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $3,000 | +200.0% | 2,250 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -80.0% | 2,250 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $5,000 | -50.0% | 2,250 | -30.8% | 0.00% | -50.0% |
| Q3 2019 | $10,000 | -47.4% | 3,250 | 0.0% | 0.00% | -42.9% |
| Q2 2019 | $19,000 | – | 3,250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INSPIRION WEALTH ADVISORS, LLC | 330,874 | $1,670,914 | 0.33% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $2,020,000 | 0.28% |
| AMUSSEN HUNSAKER ASSOCIATES LLC | 75,016 | $377,330 | 0.08% |
| Nebula Research & Development LLC | 25,708 | $129,825 | 0.07% |
| Corton Capital Inc. | 22,091 | $111,560 | 0.06% |
| Sofinnova Investments, Inc. | 142,635 | $720,307 | 0.04% |
| LAZARI CAPITAL MANAGEMENT, INC. | 11,000 | $55,550 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,369 | $123,063 | 0.02% |
| WINTON GROUP Ltd | 21,256 | $107,343 | 0.01% |
| Truvestments Capital LLC | 1,372 | $6,929 | 0.00% |